Variable Results of First-Generation Anti-HCV Enzyme Immunoassay during Follow-Up of Blood Donors

Vox Sanguinis ◽  
1993 ◽  
Vol 64 (1) ◽  
pp. 61-62
Author(s):  
G. Caspari ◽  
W.H. Gerlich ◽  
J. Beyer ◽  
H. Schmitt
Keyword(s):  
Enzyme Immunoassay ◽  
First Generation ◽  
Blood Donors

Variable Results of First-Generation Anti-HCV Enzyme Immunoassay during Follow-Up of Blood Donors

Vox Sanguinis ◽  
1993 ◽  
Vol 64 (1) ◽  
pp. 61-62 ◽  
Author(s):  
G. Caspari ◽  
W.H. Gerlich ◽  
J. Beyer ◽  
H. Schmitt
Keyword(s):  
Enzyme Immunoassay ◽  
First Generation ◽  
Blood Donors

MRI follow‐up of patients with acromegaly treated after surgery with first‐generation somatostatin receptor ligands

2021 ◽  
Author(s):  
Naia Grandgeorge ◽  
Giovanni Barchetti ◽  
Solange Grunenwald ◽  
Fabrice Bonneville ◽  
Philippe Caron
Keyword(s):  
First Generation ◽  
Somatostatin Receptor ◽  
Receptor Ligands ◽  
Somatostatin Receptor Ligands

Radiofrequency Ablation of Hepatic Metastases from Colorectal Cancer: Are Newer Generation Probes Better?

2006 ◽  
Vol 72 (10) ◽  
pp. 875-879 ◽  
Author(s):  
Aziz Ahmad ◽  
Steven L. Chen ◽  
Maihgan A. Kavanagh ◽  
David P. Allegra ◽  
Anton J. Bilchik
Keyword(s):  
Colorectal Cancer ◽  
Radiofrequency Ablation ◽  
First Generation ◽  
Hepatic Metastases ◽  
Disease Free Survival ◽  
Cancer Center ◽  
Free Survival ◽  
Alive With Disease ◽  
Disease Free

Second-generation radiofrequency ablation (RFA) probes and their successors have more power, shorter ablation times, and an increased area of ablation compared with the first-generation probes used before 2000. We examined whether the use of the newer probes has improved the clinical outcome of RFA for hepatic metastases of colorectal cancer at our tertiary cancer center. Of 160 patients who underwent RFA between 1997 and 2003, 52 had metastases confined to the liver: 21 patients underwent 46 ablations with the first-generation probes and 31 patients underwent 58 ablations with the newer probes. The two groups had similar demographic characteristics. At a median follow-up of 26.2 months, patients treated with the newer probes had a longer median disease-free survival (16 months vs 8 months, P < 0.01) and a lower rate of margin recurrence (5.2% vs 17.4%); eight patients had no evidence of disease and one patient was alive with disease. By contrast, of the 46 patients treated with the first-generation probes, 2 patients had no evidence of disease and 1 patient was alive with disease. Newer-generation probes are associated with lower rates of margin recurrence and higher rates of disease-free survival after RFA of hepatic metastases from colorectal cancer.

scholarly journals Notification and follow-up study on anti-HCV seropositive blood donors. (I).

1993 ◽  
Vol 39 (3) ◽  
pp. 627-633
Author(s):  
Kimihiro Kanemitsu ◽  
Yutaka Emmanji ◽  
Makoto Sasaki ◽  
Tsutomu Ohkawa ◽  
Shuichi Kaneko ◽  
...  
Keyword(s):  
Blood Donors ◽  
Follow Up Study

scholarly journals Lessons learned from the long-term follow-up of a first-generation aortic stent graft

2003 ◽  
Vol 37 (2) ◽  
pp. 367-373 ◽  
Author(s):  
Pierre Alric ◽  
Robert J. Hinchliffe ◽  
Peter W. Wenham ◽  
Simon C. Whitaker ◽  
Timothy A.M. Chuter ◽  
...  
Keyword(s):  
Stent Graft ◽  
First Generation ◽  
Lessons Learned ◽  
Aortic Stent Graft ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document